JohnPManisMD

Assistant Professor of Pathology, Boston Children's Hospital

Dr. Manis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
16 Rutland Sq
Boston, MA 02118
Phone+1 617-919-2618

Fax+1 617-730-0217

Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Blood Banking/Transfusion Medicine, 2008 - 2009
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1995
Tufts Medical CenterResidency, Internal Medicine, 1989 - 1991
MedStar Health/Georgetown University HospitalInternship, Internal Medicine, 1988 - 1989
SUNY Upstate Medical UniversityClass of 1988

PubMed

Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells.
Jing Zeng, My Anh Nguyen, Pengpeng Liu, Lucas Ferreira da Silva, Sébastien Levesque
Cell Stem Cell. 2024-12-11
9 citations
Humanized V(D)J-rearranging and TdT-expressing mouse vaccine models with physiological HIV-1 broadly neutralizing antibody precursors.
Sai Luo, Changbin Jing, Adam Yongxin Ye, Sven Kratochvil, Christopher A Cottrell
Proceedings of the National Academy of Sciences of the United States of America. 2023-01-03
9 citations
Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies.
Boya Liu, Christian Brendel, Divya S Vinjamur, Yu Zhou, Chad Harris
Molecular Therapy. 2022-08-03

Abstracts/Posters

Therapeutic Base Editing of Human Hematopoietic Stem Cells
John P Manis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Murine Model Of Job'S SyndromeNational Institute Of Allergy And Infectious Diseases2011
Animal CoreNational Heart, Lung, And Blood Institute2010–2011
DNA Damage Responses In B Cell DevelopmentNational Cancer Institute2009–2010
Control IG Heavy Chain Class SwitchingNational Institute Of Allergy And Infectious Diseases1994–1999